Jessica Olander, MD
MOHS-Micrographic Surgery · Westminster, CONPI 1659515658
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $384 and has fallen 54.3% since, to $176 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in CO, where the typical reported total is $1,865.
Across 87 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$313
- AbbVie$255
- Sanofi$170
- Lilly USA, LLC$154
- Novartis$129
- Regeneron Healthcare Solutions, Inc.$114
- plus $602 from 14 others
What the payments were for
- Food & beverage$1,737100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 11 | $313 |
| AbbVie | 11 | $255 |
| Sanofi | 7 | $170 |
| Lilly USA, LLC | 10 | $154 |
| Novartis | 6 | $129 |
| Regeneron Healthcare Solutions, Inc. | 6 | $114 |
| Pfizer | 5 | $86 |
| Sun Pharmaceutical Industries Inc. | 5 | $69 |
| Journey Medical Corporation | 4 | $59 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $58 |
| Johnson & Johnson | 3 | $57 |
| Incyte Corporation | 3 | $52 |
| Amgen | 2 | $48 |
| LEO Pharma Inc. | 2 | $43 |
| Almirall LLC | 2 | $37 |
| Biofrontera Inc. | 2 | $28 |
| EPI Health, LLC | 1 | $24 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
| VYNE Pharmaceuticals Inc. | 1 | $12 |
How this compares
$1,737 in reported general payments places this provider in the 45th percentile of 37 mohs-micrographic surgery providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 46 | $342 |
| Doxycycline Hyclate | 15 | $133 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Westminster
- Anastasia BenoitWestminster$3K
- Joel CohenGreenwood Village$426K
- Shawn AllenBoulder$69K
- Kevin MottLoveland$33K
- Karen NernEdwards$28K
- Vinh ChungColorado Springs$10K
- Brett MathesonColorado Spgs$10K
- Misha MillerDenver$5K
- Joseph WildeFort Collins$5K
- Samantha GhiselliGlendale$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.